UCB Dedicates Site for $2 Billion Gwinnett Biologics Campus — 330 Jobs Planned
UCB's October 9 ceremony at Rowen marked a new step for its planned biologics manufacturing campus and Georgia's growing life sciences sector.
GWINNETT COUNTY, Ga. — Global biopharmaceutical company UCB dedicated the site of its planned U.S. biologics manufacturing campus at the Rowen innovation district on October 9, 2026, advancing one of Georgia's largest announced life-sciences investments.
The ceremony marks a site dedication, not the opening of a finished factory. UCB expects an investment of about $2 billion as the campus is built out over the coming years.
A major project with ambitious projections
UCB's plan calls for a facility of approximately 460,000 square feet on 79 acres within the Rowen district. The company projects roughly 330 permanent highly skilled jobs and more than 1,000 construction jobs; these figures describe expected opportunities, not completed hiring.
UCB and local economic-development officials also cite a projected $5 billion total economic impact. Like other forecasts, this estimate depends on how the project is delivered and operates in practice.
What will the facility make?
Biologics are complex medicines developed using living systems. UCB says the planned Georgia operation will add U.S. manufacturing capacity within its broader global network, with digital-first production that uses automation, robotics and data-intensive processes.
The company develops medicines for people living with serious neurological and autoimmune conditions. Manufacturing such treatments calls for tightly controlled processes and specialized technical workers.
Why Gwinnett and Rowen?
Rowen is a planned 2,000-acre research and innovation community near Georgia Highway 316. UCB already has a long-standing regional presence: its U.S. headquarters have been based in metro Atlanta for more than three decades, and it reported employing more than 400 people in Georgia at the time of the ceremony.
Gwinnett County has invested in roads, water and sewer infrastructure to support development at Rowen. The project's scale means residents should pay attention both to new opportunities and to how infrastructure, public incentives and long-term local needs are managed.
Where opportunity may emerge
UCB says it is seeking relationships with universities, schools and workforce-training groups to develop future biomanufacturing talent. During construction, opportunities may extend to qualified skilled-trades companies, site services and supporting vendors. Permanent operations will require specialized workers and suppliers.
Those opportunities should not be confused with a public application process that has already opened. Residents and businesses should check UCB's official careers and supplier channels for current information, rather than assume a projected job has been posted.
The Georgia inside the story
This is about more than one international company's investment. UCB's choice connects Gwinnett County's manufacturing base with research, training and advanced medicine. The most meaningful measure will come later: the jobs filled, the skills developed and whether the surrounding Georgia community benefits from that activity.
ANG continues to document Georgia businesses, communities and industries through its statewide directory and Georgia Stories coverage.